BSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.
Shelter Pharma Ltd: key numbers
- Share price
- ₹39.60
- Market cap
- ₹68.52 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 7.6×Sector 46.5×
- Promoter holding
- 46.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma Preferential Issue
Shelter Pharma Ltd has allotted 4,65,000 equity shares via a preferential issue at ₹42.25 per share. This transaction resulted in a total capital infusion of ₹1.96 Crore.
- Value
- ₹1.96 Cr
Shelter Pharma Convertible Warrants
Shelter Pharma Limited approved the conversion of 465,000 warrants into equity shares for its promoter. This allotment follows the receipt of the remaining exercise price of Rs. 1.47 Crore.
- Value
- ₹1.47 Cr
Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Shelter Pharma Management Change
Shelter Pharma Limited has regularized Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director for a five-year term, following approval by shareholders at the 19th AGM.
Shelter Pharma Annual General Meeting
Shelter Pharma Limited conducted its 19th Annual General Meeting on September 29, 2026. Key agenda items included adopting financial statements and ratifying material related party transactions.
Shelter Pharma Bags ₹0.1 Cr Order from Berlin International Company
Shelter Pharma received a ₹0.10 Cr export order from Berlin International Company for D3 CURE nutraceuticals. The order broadens its global nutraceutical customer base.
- Value
- ₹0.10 Cr
- From
- Berlin International Company
- Execution
- mutually agreed timelines as per purchase order schedule
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.